“…Nevertheless, micelles present the advantage of being more stable than liposomes (Andrade et al, 2011a). The versatility of micelles explains why they have been proposed as vehicles for solubilization and delivery of a variety of drugs like doxorubicin (Chen et al, 2012), paclitaxel (Kato et al, 2011;Lee et al, 2008), rifampicin (Moretton et al, 2013), calcitonin (Baginski et al, 2012), cyclosporine A (Di Tommaso et al, 2012) among others, being some formulations in clinical trials (Kato et al, 2011;Lee et al, 2008). Due to the development noted in the biotechnology field, biopharmaceuticals have emerged as an alternative to conventional drugs in the treatment of many diseases.…”